3

FORM 3 - DR. LANGECKER

Company: Oncotelic Therapeutics, Inc.
Filed: June 30, 2009
Period of Report: June 29, 2009
Accession Number: 0001181431-09-032810

View Document ↗ View on SEC.gov ↗